Atsena Therapeutics

Close-up of human eye
Biotech

Atsena gene therapy hits safety goals, closes retinal splits

Gene therapy outfit Atsena Therapeutics has debuted data showing its eye disease candidate led to no serious treatment-related adverse events.
Darren Incorvaia May 19, 2025 12:59pm
lighthouse in stormy night

Gene therapy biotech secures $150M for eye disease candidates

Apr 2, 2025 7:30am
close-up image of an eye

Atsena downsizes to funnel money toward new capsid program

Oct 5, 2023 1:47pm
ladder chutes and ladders parachute

Seagen finally finds new CEO—Chutes & Ladders

Nov 11, 2022 9:30am
Dry eye

Eyeing phase 3, Atsena raises $55M financing for gene therapy

Dec 16, 2020 7:30am